Home

Astrazeneca Pharma India Ltd EPS

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

EPS

₹ 67.05

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Astrazeneca Pharma India Ltd is ₹ 67.05 as of 21 Feb 25 .
  • The earning per share of Astrazeneca Pharma India Ltd changed from ₹ 21.54 to ₹ 12.34 over 7 quarters. This represents a CAGR of -27.26% .

Historical Earning per Share of Astrazeneca Pharma India Ltd

No data available

* All values are in

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

17,171 Cr

EPS

67.1

P/E Ratio (TTM)

102.4

P/B Ratio (TTM)

25.3

Day’s High

7117.0

Day’s Low

6803.6

DTE

0.0

ROE

18.9

52 Week High

8139.85

52 Week Low

4050.15

ROCE

23.9

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20256868.75
20 Feb 20256976.5
19 Feb 20256942.7
18 Feb 20256958
17 Feb 20257030.05
14 Feb 20257096.35
13 Feb 20257410.6
12 Feb 20257494.65
11 Feb 20257466.85
10 Feb 20257535.1

BlinkX Score for Astrazeneca Pharma India Ltd

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

17,172

Asset Value

Value addition

17.0 X

955

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Astrazeneca Pharma India Ltd17171
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Astrazeneca Pharma India Ltd News Hub

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30

Read more

08 Aug 24

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag

Read more

08 Aug 24

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI

Read more

24 Sept 24

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini

Read more

24 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Astrazeneca Pharma India Ltd

What is the EPS of Astrazeneca Pharma India Ltd stock?

The Earnings Per Share (EPS) of Astrazeneca Pharma India Ltd is 67.05. An EPS is the amount of net income attributed to each share of a common stock.

How is Astrazeneca Pharma India Ltd EPS calculated?

The EPS of Astrazeneca Pharma India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Astrazeneca Pharma India Ltd report its EPS?

Astrazeneca Pharma India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Astrazeneca Pharma India Ltd EPS?

Factors that influence the EPS of Astrazeneca Pharma India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Astrazeneca Pharma India Ltd EPS growth indicate future performance?

Yes, consistent growth in Astrazeneca Pharma India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions